These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11180032)

  • 1. Definition and axioms of net treatment benefit.
    Kessler KM; Kessler DK
    Clin Pharmacol Ther; 2001 Jan; 69(1):1-6. PubMed ID: 11180032
    [No Abstract]   [Full Text] [Related]  

  • 2. The number remaining at risk: an adjunct to the number needed to treat.
    Massel D; Cruickshank MK
    Can J Cardiol; 2002 Mar; 18(3):254-8. PubMed ID: 11907613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An assessment of clinically useful measures of the consequences of treatment.
    Laupacis A; Sackett DL; Roberts RS
    N Engl J Med; 1988 Jun; 318(26):1728-33. PubMed ID: 3374545
    [No Abstract]   [Full Text] [Related]  

  • 4. [Standard treatment of chronic hepatitis B].
    Manns MP; Caselmann WH; Wiedmann KH; Wedemeyer H
    Z Gastroenterol; 2004 Aug; 42(8):687-91. PubMed ID: 15314716
    [No Abstract]   [Full Text] [Related]  

  • 5. [Standard treatment of acute and chronic hepatitis C].
    Zeuzem S
    Z Gastroenterol; 2004 Aug; 42(8):714-9. PubMed ID: 15314722
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immune prophylaxis of hepatitis B].
    Jilg W; Rink C; Kallinowski B
    Z Gastroenterol; 2004 Aug; 42(8):698-702. PubMed ID: 15314718
    [No Abstract]   [Full Text] [Related]  

  • 7. [Procedures for problematic situations with hepatitis B].
    Blum HE; Berg T; Tillmann HL; Von Weizsäcker F
    Z Gastroenterol; 2004 Aug; 42(8):692-7. PubMed ID: 15314717
    [No Abstract]   [Full Text] [Related]  

  • 8. Benefit assessment of therapeutic products: the Centers for Education and Research on Therapeutics.
    Califf RM;
    Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):5-16. PubMed ID: 16506270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The whole story.
    Kiser K
    Minn Med; 2007 Nov; 90(11):8, 10. PubMed ID: 18072465
    [No Abstract]   [Full Text] [Related]  

  • 10. What is the risk of sham surgery in Parkinson disease clinical trials? A review of published reports.
    Landau W
    Neurology; 2006 Jun; 66(11):1788-9; author reply 1788-9. PubMed ID: 16769977
    [No Abstract]   [Full Text] [Related]  

  • 11. In response to Dr. McCormick (2002;1:179-180).
    Polgár C; Major T; Fodor J
    Brachytherapy; 2003; 2(2):117-8; author reply 118. PubMed ID: 15062151
    [No Abstract]   [Full Text] [Related]  

  • 12. Comment on "Steady State Solutions to PBPK Models and Their Applications to Risk Assessment I: Route to Route Extrapolation of Volatile Chemicals," by Chiu and White in Risk Analysis, 26(3), 769-780.
    Bogen KT
    Risk Anal; 2006 Dec; 26(6):1415; author reply 1417-8. PubMed ID: 17184387
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk perception and communication.
    Greenberg M; Lowrie K
    Risk Anal; 2009 Aug; 29(8):1059-60. PubMed ID: 19659546
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessing a structured, quantitative health outcomes approach to drug risk-benefit analysis.
    Garrison LP; Towse A; Bresnahan BW
    Health Aff (Millwood); 2007; 26(3):684-95. PubMed ID: 17485745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meeting the National Service Framework for coronary heart disease: which patients have untreated high blood pressure?
    Marshall T; Rouse A
    Br J Gen Pract; 2001 Jul; 51(468):571-4. PubMed ID: 11462320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk assessment scales for pressure ulcers: a theoretical, methodological, and clinical perspective.
    Halfens RJ
    Ostomy Wound Manage; 2000 Aug; 46(8):36-40, 42-4. PubMed ID: 11189546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. And so we model: the ineffective use of mathematical models in ecological risk assessments.
    Tannenbaum LV
    Integr Environ Assess Manag; 2007 Oct; 3(4):473-5. PubMed ID: 18046795
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence of an internecine conflict within the practice of environmental risk assessment?
    Bridges TS; Glaser D
    Integr Environ Assess Manag; 2008 Apr; 4(2):138. PubMed ID: 18494115
    [No Abstract]   [Full Text] [Related]  

  • 19. On the evaluation of intervention outcome risks for patients with ischemic heart disease.
    Ferguson TB
    Circulation; 2008 Jan; 117(3):333-5. PubMed ID: 18212296
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diagnosis and treatment of acute and chronic hepatitis C--procedure in difficult situations].
    Schmiegel WH
    Z Gastroenterol; 2004 Aug; 42(8):720-3. PubMed ID: 15314723
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.